Search Results - "Willoughby, Ernest"
-
1
A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue
Published in Psychosomatic medicine (01-02-2008)“…The purpose of this study was to assess the efficacy of cognitive behavior therapy (CBT) as a treatment for multiple sclerosis (MS) fatigue. A randomized…”
Get full text
Journal Article -
2
Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force
Published in Annals of neurology (01-09-1997)“…This article provides recommendations from the National Multiple Sclerosis Society's Clinical Outcomes Assessment Task Force. The Task Force was appointed in…”
Get more information
Journal Article -
3
GEOGRAPHIC VARIATION IN COLOR, MEASUREMENTS, AND MOLT OF THE LESSER GOLDFINCH IN NORTH AMERICA DOES NOT SUPPORT SUBSPECIFIC DESIGNATION
Published in The Condor (Los Angeles, Calif.) (01-05-2007)“…I examined 963 study skins of Lesser Goldfinches (Carduelis psaltria) from the United States to central Mexico, for color, measurements, molt, and plumage…”
Get full text
Journal Article -
4
Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo-Controlled, Outpatient Study
Published in Headache (01-04-1998)“…Rizatriptan is a novel 5‐HT1B/1D agonist which is rapidly absorbed after oral administration. The efficacy and tolerability of oral rizatriptan (5 mg and 10…”
Get full text
Journal Article -
5
MOLT AND PLUMAGE TERMINOLOGY OF HOWELL ET AL. (2003) STILL MAY NOT REFLECT HOMOLOGIES
Published in The Condor (Los Angeles, Calif.) (01-02-2004)“…Forty-five years ago Humphrey and Parkes (1959) introduced their system of nomenclature for molts and plumages (the H-P system). They claimed that their…”
Get full text
Journal Article -
6
The latitude gradient for multiple sclerosis prevalence is established in the early life course
Published in Brain (London, England : 1878) (17-08-2021)“…Abstract The strongest epidemiological clue that the environment at the population level has a significant impact on the risk of developing multiple sclerosis…”
Get full text
Journal Article -
7
Multiple sclerosis mortality in New Zealand: a nationwide prospective study
Published in Journal of neurology, neurosurgery and psychiatry (01-07-2023)“…BackgroundMortality data from Europe and North America show a shorter life expectancy for people with multiple sclerosis (MS). It is not known if a similar…”
Get full text
Journal Article -
8
Incidence and prevalence of NMOSD in Australia and New Zealand
Published in Journal of neurology, neurosurgery and psychiatry (01-08-2017)“…ObjectivesWe have undertaken a clinic-based survey of neuromyelitis optica spectrum disorders (NMOSDs) in Australia and New Zealand to establish incidence and…”
Get full text
Journal Article -
9
-
10
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome
Published in Brain (London, England : 1878) (04-04-2024)“…Low serum levels of 25-hydroxyvitamin D [25(OH)D] and low sunlight exposure are known risk factors for the development of multiple sclerosis. Add-on vitamin D…”
Get full text
Journal Article -
11
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Published in Nature genetics (01-07-2009)“…To identify multiple sclerosis (MS) susceptibility loci, we conducted a genome-wide association study (GWAS) in 1,618 cases and used shared data for 3,413…”
Get full text
Journal Article -
12
NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand
Published in Journal of neurology (01-02-2022)“…Background We studied the prevalence of neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) in Indigenous populations of Australia and…”
Get full text
Journal Article -
13
The clinical profile of NMOSD in Australia and New Zealand
Published in Journal of neurology (01-05-2020)“…Neuromyelitis optica spectrum disorders (NMOSD) are an inflammation of the central nervous system associated with autoantibodies to aquaporin-4. We have…”
Get full text
Journal Article -
14
American academy of neurology annual meeting
Published in International MS journal (01-05-2011)“…The American Academy of Neurology (AAN) Annual Meeting was held in Toronto, Canada from 10 to 17 April, 2010. As usual, multiple sclerosis (MS) featured…”
Get more information
Journal Article -
15
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation
Published in Frontiers in neurology (16-06-2020)“…Neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) show overlap in their clinical features. We performed an analysis of relapses with…”
Get full text
Journal Article -
16
MRI Patterns Distinguish Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis (4128)
Published in Neurology (13-04-2021)“…Abstract only…”
Get full text
Journal Article -
17
The latitude gradient for multiple sclerosis prevalence is established in the early lifecourse
Published in Brain (London, England : 1878) (11-03-2021)“…The strongest epidemiological clue that the environment at the population level has a significant impact on the risk of developing multiple sclerosis (MS) is…”
Get full text
Journal Article -
18
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
Published in Frontiers in neurology (09-09-2021)“…Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) are inflammatory diseases of the CNS. Overlap in the clinical and MRI features of…”
Get full text
Journal Article -
19
Geographic Variation in Color, Measurements, and Molt of the Lesser Goldfinch in North America Does not Support Subspecific Designation
Published in The Condor (Los Angeles, Calif.) (01-05-2007)“…Abstract I examined 963 study skins of Lesser Goldfinches (Carduelis psaltria) from the United States to central Mexico, for color, measurements, molt, and…”
Get full text
Journal Article -
20
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
Published in Brain (London, England : 1878) (01-05-1999)“…The primary clinical outcome measure for evaluating multiple sclerosis in clinical trials has been Kurtzke's expanded disability status scale (EDSS). New…”
Get full text
Journal Article